Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials

Ponce, S.Calvo, E.De Miguel, M. J.Sessa, C.Flor, M. J.Drilon, A.Falcon, A.Sanchez Simon, I.Nunez, R.Luepke, X. E.Cuevas-Melendez, N.Lopez-Vilarino, J.Fudio, S.Siguero, M.Cullell-Young, M.Kahatt, C.Zeaiter, A.Paz-Ares, L.2025-01-072025-01-072019-10-011556-0864https://hdl.handle.net/10668/27252enSCLCLurbinectedinCombinationLurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trialsconference outputopen access10.1016/j.jtho.2019.08.17581556-1380http://www.jto.org/article/S1556086419324414/pdf492162204243